PHAT
Phathom Pharmaceuticals Inc.
$11.74
+$0.53(+4.73%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$778.96M
Volume
560.66K
52W Range
$2.21 - $19.50
Target Price
$20.50
EPS Estimates Overview
| Current Quarter | $-0.42 | Next Quarter | $-0.24 |
| Current Year | $-2.77 | Next Year | $0.23 |
| QoQ Growth | +42.9% | YoY Growth | +108.3% |
| 3Y EPS CAGR | -10.8% | Target Price | $20.50 |
| Consensus | Buy | Upside | +74.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHAT | $11.74 | +4.7% | 560.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phathom Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW